Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06232083 | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) | recruiting | Phase 1 | 20 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 9, 2025 |
| clinicaltrials |
| NCT07036211 | Transmission of Oncogenic HPV Infection Among Families(TREVINO) | not yet recruiting | — | 700 | Tampere University HospitalOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06977594 | Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer | not yet recruiting | N/A | 1,000 | Seoul National University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07028242 | Ultrasound and Histology in AEH and Early EEC Treated Conservatively(ULTRA-SAFE) | not yet recruiting | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT07003620 | Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial | recruiting | Phase 2 | 34 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT05996783 | Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial(ScreenUrSelf) | active not recruiting | N/A | 48,000 | Universiteit AntwerpenOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT07015593 | Patient Journey in Advanced Gynecologic Cancers | not yet recruiting | — | 780 | Tongji HospitalOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 150 | Cancer Research UKOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05994300 | Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer | active not recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06998394 | A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer | recruiting | Phase 2 | 30 | Xiangbo WanOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06999824 | Revisiting the Concept of Nerve Sparing Radical Hysterectomy(Neuro-Nerve) | not yet recruiting | — | 15 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT03101995 | Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease | recruiting | Phase 2 | 18 | National Institute of CancerologíaOTHER_GOV | 1 | May 28, 2025 | clinicaltrials |
| NCT04165460 | Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients | enrolling by invitation | N/A | 92 | National Institute of CancerologíaOTHER_GOV | 1 | May 28, 2025 | clinicaltrials |
| NCT06156514 | Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer(MICHELE) | recruiting | Phase 3 | 140 | National Institute of CancerologíaOTHER_GOV | 1 | May 28, 2025 | clinicaltrials |
| NCT06080841 | Curcumin Supplementation in Cervical Cancer | recruiting | N/A | 30 | National Institute of CancerologíaOTHER_GOV | 1 | May 25, 2025 | clinicaltrials |
| NCT06986057 | Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer | not yet recruiting | Phase 2 | 28 | Shandong Tumor HospitalOTHER | 0 | May 22, 2025 | clinicaltrials |
| NCT06981858 | A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 34 | Chongqing University Cancer HospitalOTHER | 0 | May 21, 2025 | clinicaltrials |
| NCT06981182 | EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults(EQUITA) | not yet recruiting | N/A | 300 | University of SunderlandOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT03061435 | Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.(Vulvar-AIN) | recruiting | N/A | 110 | Dr. Danielle VicusOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT03201861 | Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women | recruiting | Phase 3 | 762 | RenJi HospitalOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06459687 | Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer | recruiting | Phase 3 | 440 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 14, 2025 | clinicaltrials |
| NCT05062707 | Early Ageing During Therapy in AYA Cancer Patients | recruiting | — | 120 | University Medical Center GroningenOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06052033 | Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection | recruiting | N/A | 40 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05938192 | Multimodality Treatments of HPV-related Lesions of the Female Genital Tract | recruiting | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT06942416 | Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer | recruiting | Phase 2 | 36 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT05947513 | Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial(CuPRAC) | recruiting | N/A | 27 | Addis Ababa UniversityOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT05266898 | Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV(AGO-Gard) | recruiting | Phase 4 | 250 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT06929234 | Effects of Health Education on Knowledge, Attitude and Screening for Cervical Cancer in Women | not yet recruiting | N/A | 30 | Ordu UniversityOTHER | 0 | Apr 16, 2025 | clinicaltrials |
| NCT05857631 | Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study(PARCERII) | recruiting | N/A | 90 | Tata Memorial CentreOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06921798 | Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program | not yet recruiting | N/A | 3,000 | University of VirginiaOTHER | 0 | Apr 10, 2025 | clinicaltrials |
| NCT05421650 | Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr | recruiting | N/A | 240 | CHA UniversityOTHER | 5 | Apr 9, 2025 | clinicaltrials |
| NCT06916117 | Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC | not yet recruiting | Phase 2 | 30 | RenJi HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT05284877 | The Organ Transplant Recipient HPV and Skin Cancer Study | recruiting | — | 1,500 | Merete HaedersdalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06558682 | Neoadjuvant Therapy in Cervical Cancer | recruiting | N/A | 48 | Qilu Hospital of Shandong UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06878222 | Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC | recruiting | Phase 2 | 35 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06882447 | A Study of QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer(QL1706) | not yet recruiting | Phase 2 | 35 | Northern Jiangsu People's HospitalOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT06786780 | Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids(ECCO) | enrolling by invitation | Phase 2 | 50 | Chongqing University Cancer HospitalOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT04802876 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors(ACROPOLI) | active not recruiting | Phase 2 | 184 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04915495 | The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia | enrolling by invitation | N/A | 400 | Guided TherapeuticsINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04516616 | Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer | active not recruiting | Phase 2 | 85 | Huazhong University of Science and TechnologyOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06078514 | Sexual Function and Quality of Life After LEEP: a Prospective Multi-Center Study(SEQUEL) | recruiting | — | 1,000 | Tampere University HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06288360 | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC | recruiting | Phase 2 | 40 | Tongji HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05229679 | HPV-based Screening Among Women 23-29 Years of Age | recruiting | N/A | 180,000 | Karolinska InstitutetOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05640700 | Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia | recruiting | — | 90 | Hadassah Medical OrganizationOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06641635 | Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer | recruiting | Phase 3 | 440 | Peking Union Medical College HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06882473 | A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer | not yet recruiting | N/A | 20 | Peking University Third HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06870565 | Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma | not yet recruiting | Phase 3 | 238 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | Mar 17, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jul 9, 2025source: clinicaltrials